Login to Your Account

NeuroSearch Spinouts Acesion, Aniona Picking up CNS Assets

By Nuala Moran
BioWorld International Correspondent

Wednesday, December 21, 2011
LONDON – NeuroSearch A/S is spinning out two start-ups to take forward programs that were parked in September when the company announced it was restructuring and would be focusing all resources on its Phase III Huntington's disease product, Huntexil.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription